Tao Wang
Texas Children's Hospital(US)Children's Cancer Center(US)Kingston Health Sciences Centre(CA)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, CAR-T cell therapy research, Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia(2016)1,340 cited
- → Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974(2013)825 cited
- → Targeting cardiac fibrosis with engineered T cells(2019)762 cited
- → Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors(2016)488 cited
- → Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma(2020)372 cited
- → Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study(2019)318 cited